Skip to main content

Advertisement

SpringerLink
Log in

Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To describe the role of sex steroid-dependent growth of muscle-invasive bladder cancer (MIBC) and the role of single-nucleotide polymorphisms (SNP) located on chromosome 8q24 as a molecular explanation for gender-specific differences in the incidence and outcome of MIBC.

Methods

A detailed, non-systematic analysis was performed for articles and reviews investigating the role of sex steroids in the development and progression of MIBC between 2000 and 2012.

Results

Localized MIBCs overexpress the androgen receptor (AR), whereas in lymph node-positive stages, loss of AR expression has been found. High-risk SNPs of genes on chromosome 8q24, that is, the rs2294008 of prostate stem cell antigen (PSCA) gene, have been linked with increased susceptibility for MIBC. The PSCA gene possesses an androgen-responsive element (ARE) in its promoter region. Recent studies suggest that loss of AR responsiveness to the PSCA promoter may result in the induction of an androgen-independent mechanism, that is, the insulin-like growth factor-binding protein 2 signalling pathway—a key event in the development of hormone-independent prostate cancer—and this may increase the metastatic potential. In females, it can be hypothesized that due to the altered androgen levels, these mechanisms may be initiated earlier during tumor progression in females and result in inferior survival compared to males.

Conclusion

Muscle-invasive bladder cancer (MIBC) is a sex steroid-dependent tumor. AREs in the promoter region of high-risk genes may drive tumor progression and result in loss of androgen responsiveness, which eventually leads to the activation of androgen-independent processes forming the metastatic potential. The determination of the AR status in cystectomy specimens additionally offers new adjuvant approaches after cystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, Meryn S, Schlegel PN, Shariat SF (2012) Sex disparities in cancer mortality: the risks of being a man in the U. S. J Urol 12:05774–05776

    Google Scholar 

  2. Sammon JD, Morgan M, Djahangirian O, Trinh QD, Sun M, Ghani KR, Jeong W, Jhaveri J, Ehlert M, Schmitges J, Bianchi M, Shariat SF, Perrotte P, Rogers CG, Peabody JO, Menon M, Karakiewicz PI (2012) Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int 110(9):1301–1309

    Article  PubMed  Google Scholar 

  3. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3):300–308

    Article  PubMed  Google Scholar 

  4. Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large german multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9(6):481–489

    Article  PubMed  Google Scholar 

  5. Hollenbeck BK, Dunn R, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP Jr, Miller DC (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116(22):5235–5242

    Article  PubMed  Google Scholar 

  6. Waliszewski P, Waliszewska MK, Hemstreet GP 3rd, Hurst RE (1997) Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines. Urol Oncol 3(5–6):141–147

    PubMed  CAS  Google Scholar 

  7. Mir C, Shariat SF, van der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR (2011) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int 108(1):24–30

    Article  PubMed  Google Scholar 

  8. Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS (2004) Androgen receptor expression is inversely correlated with pathologic tumour stage in bladder cancer. Urology 64(2):383–388

    Article  PubMed  Google Scholar 

  9. Bolenz C, Lotan Y, Ashfaq R, Shariat SF (2009) Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 56(6):1093–1095

    Article  PubMed  Google Scholar 

  10. Gakis G, Efstathiou JA, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A (2012) ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. doi:10.1016/j.eururo.2012.08.009

    PubMed  Google Scholar 

  11. Gakis G, Schilling D, Bedke J, Sievert KD, Stenzl A (2010) Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery. BJU Int 105(4):468–471

    Article  PubMed  Google Scholar 

  12. Gakis G, Stenzl A, Renninger M (2012) Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy. Scand J Urol Nephrol. doi: 10.3109/00365599.2012.723045

  13. Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H (2011) Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog. doi:10.1002/mc.21833

    PubMed  Google Scholar 

  14. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H (2012) Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog. doi:10.1002/mc.21978

    PubMed  Google Scholar 

  15. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99(7):558–568

    Article  PubMed  CAS  Google Scholar 

  16. Tuygun C, Kankaya D, Imamoglu A, Sertcelik A, Zengin K, Oktay M, Sertcelik N (2011) Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 29(1):43–51

    Article  PubMed  CAS  Google Scholar 

  17. Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25(1):85–96

    Article  PubMed  CAS  Google Scholar 

  18. Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S (2012) Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 109(11):1716–1726

    Article  PubMed  CAS  Google Scholar 

  19. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumour tiss. Cancer 106(12):2610–2616

    Article  PubMed  CAS  Google Scholar 

  20. Tincello DG, Taylor AH, Spurling SM, Bell SC (2009) Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract. J Urol 181(3):1474–1482

    Article  PubMed  CAS  Google Scholar 

  21. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4):457–463

    Article  PubMed  Google Scholar 

  22. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O’Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team (2011) Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305(22):2295–2303

    Article  PubMed  CAS  Google Scholar 

  23. Chu LW, Meyer TE, Li Q, Menashe I, Yu K, Rosenberg PS, Huang WY, Quraishi SM, Kaaks R, Weiss JM, Hayes RB, Chanock SJ, Hsing AW (2010) Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev 19(7):1848–1854

    Article  PubMed  CAS  Google Scholar 

  24. Ishak MB, Giri VN (2011) A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies. Cancer Epidemiol Biomarkers Prev 20(8):1599–1610

    Article  PubMed  Google Scholar 

  25. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Guarrera S, Polidoro S, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41(9):991–995

    Article  PubMed  CAS  Google Scholar 

  26. Bahrenberg G, Brauers A, Joost HG, Jakse G (2000) Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 275(3):783–788

    Article  PubMed  CAS  Google Scholar 

  27. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE (2002) Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol 16(10):2323–2337

    Article  PubMed  CAS  Google Scholar 

  28. Zhigang Z, Wenlus S (2008) Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia. Int J Cancer 122(4):864–870

    Article  PubMed  Google Scholar 

  29. Wang S, Tang J, Wang M, Yuan L, Zhang Z (2010) Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 31(4):621–624

    Article  PubMed  Google Scholar 

  30. Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE (2000) Prostate Stem Cell Antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19(10):1288–1296

    Article  PubMed  CAS  Google Scholar 

  31. Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L (2011) Androgen deprivation causes epithelial–mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res. doi:10.1158/0008-5472.CAN-11-3004

    Google Scholar 

  32. Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ, Mongan NP (2011) Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog 501(12):931–944

    Article  Google Scholar 

  33. Metzger E, Wissmann M, Yin N, Müller JM, Schneider R, Peters AH, Günther T, Buettner R, Schüle R (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057):436–439

    PubMed  CAS  Google Scholar 

  34. Miyake H, Hara I, Yamanaka K, Muramaki M, Eto H (2005) Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder. BJU Int 95(7):987–991

    Article  PubMed  CAS  Google Scholar 

  35. Reis-Filho JS, Pusztai L (2011) Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378(9805):1812–1823

    Article  PubMed  CAS  Google Scholar 

  36. Gakis G, Schwentner C, Todenhoefer T, Stenzl A (2012) Current status of molecular markers for prognostication and outcome in invasive bladder cancer. BJU Int. doi:10.1111/j.1464-410X.2011.10839.x

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Urology, Eberhard-Karls University, Hoppe-Seyler Strasse 3, 72076, Tübingen, Germany

    Georgios Gakis & Arnulf Stenzl

Authors
  1. Georgios Gakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arnulf Stenzl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgios Gakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gakis, G., Stenzl, A. Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity. World J Urol 31, 1059–1064 (2013). https://doi.org/10.1007/s00345-013-1037-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1037-z

Keywords

Search

Navigation